AR015362A1 - Uso de una composicion topicamente activa para la manufactura de un medicamento util para el tratamiento de acne vulgaris y/o para producir efectos anti-envejecimiento - Google Patents

Uso de una composicion topicamente activa para la manufactura de un medicamento util para el tratamiento de acne vulgaris y/o para producir efectos anti-envejecimiento

Info

Publication number
AR015362A1
AR015362A1 ARP980100615A ARP980100615A AR015362A1 AR 015362 A1 AR015362 A1 AR 015362A1 AR P980100615 A ARP980100615 A AR P980100615A AR P980100615 A ARP980100615 A AR P980100615A AR 015362 A1 AR015362 A1 AR 015362A1
Authority
AR
Argentina
Prior art keywords
treatment
acne vulgaris
manufacture
topically active
active composition
Prior art date
Application number
ARP980100615A
Other languages
English (en)
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of AR015362A1 publication Critical patent/AR015362A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Uso de una composicion topicamente activa para la manufactura de un medicamento util para el tratamiento de Acne Vulgaris y/o para producir efectosanti-envejecimiento en la superficie de la piel que comprende una cantidad efectiva de una composiciontopicamente activa que comprende un primeragente topicamente activo. Más específicamente, la presente invencion se refiere al uso de una proteasa, como el primer activo en una composicionefectiva para el tratamiento del Acne Vulgaris y/o para producir efectos anti-envejecimiento en la piel de un mamífero.
ARP980100615A 1997-02-12 1998-02-11 Uso de una composicion topicamente activa para la manufactura de un medicamento util para el tratamiento de acne vulgaris y/o para producir efectos anti-envejecimiento AR015362A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3760597P 1997-02-12 1997-02-12
US1556598A 1998-01-29 1998-01-29

Publications (1)

Publication Number Publication Date
AR015362A1 true AR015362A1 (es) 2001-05-02

Family

ID=26687555

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100615A AR015362A1 (es) 1997-02-12 1998-02-11 Uso de una composicion topicamente activa para la manufactura de un medicamento util para el tratamiento de acne vulgaris y/o para producir efectos anti-envejecimiento

Country Status (10)

Country Link
US (2) US20020172672A1 (es)
CN (1) CN1137677C (es)
AR (1) AR015362A1 (es)
AU (1) AU749215B2 (es)
BR (1) BR9812996A (es)
CA (1) CA2280747A1 (es)
DE (1) DE19882420T1 (es)
IL (1) IL131322A0 (es)
MX (1) MXPA99007442A (es)
SE (1) SE9904059D0 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2684604A1 (en) * 2007-05-15 2008-11-27 Puretech Ventures Methods and compositions for treating skin conditions
JP2014500275A (ja) 2010-12-06 2014-01-09 フォリカ，インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
KR102380636B1 (ko) 2015-12-28 2022-03-31 알루멘드, 엘엘씨 피부 자극에 영향을 미치는 조성물 및 방법
WO2020146353A1 (en) 2019-01-08 2020-07-16 Alumend, Llc Topical compositions containing low molecular weight chitosan derivatives
IL297330A (en) * 2020-04-15 2022-12-01 Henlez Aps Preparations and methods for treating conditions related to hair follicles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215740A (en) * 1991-10-25 1993-06-01 Church & Dwight Co., Inc. Buffering system for anticalculus dentifrices
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
AU7656894A (en) * 1993-09-15 1995-04-03 Unilever Plc Skin care method and composition
FR2737115B1 (fr) * 1995-07-25 1997-08-22 Oreal Composition stable contenant une enzyme
US5962015A (en) * 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Stabilized liposomes

Also Published As

Publication number Publication date
MXPA99007442A (es) 2004-09-01
US20020172672A1 (en) 2002-11-21
AU6534598A (en) 1998-11-24
BR9812996A (pt) 2000-08-15
IL131322A0 (en) 2001-01-28
US20040022780A1 (en) 2004-02-05
DE19882420T1 (de) 2001-02-15
CA2280747A1 (en) 1998-11-05
SE9904059D0 (sv) 1999-11-10
CN1137677C (zh) 2004-02-11
CN1258215A (zh) 2000-06-28
AU749215B2 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
NO20020299D0 (no) Behandling og sammensetning for oppnåelse av antialdring av hud med Corneum Protease aktivering
DE60327528D1 (de) Transdermale botulinum-toxin-enthaltende verbindungen
ES2160239T3 (es) Composicion farmaceutica filmogena para la administracion transdermica.
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
AR040305A1 (es) Vendaje hemostatico para heridas que contiene un polisacarido modificado con aldehido y agentes hemostaticos
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
ES2133000T3 (es) Composicion cosmetica y/o dermatologica que contiene al menos un precursor de agente activo y un poli(acido 2-acrilamido 2-metilpropano sulfonico) reticulado.
DE60122312D1 (de) Membranverabreichungssystem für wirkstoffe
HK1116683A1 (en) New pharmaceutical compositions containing hyaluronic acid or its derivatives and collagenase for the topical treatment of wounds, burns and ulcers
ES2185050T3 (es) Utilizacion de la octoxiglicerina en una composicion cosmetica y/o dermatologica como agente activo para el tratamiento de la seborrea y/o del acne.
AR004089A1 (es) Utilizacion de un antagonista de substancia p en una composicion topica , como agente antitranspirante.
WO2006007487A3 (en) Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
WO2000064405A3 (en) Treating hair by targeting enzymes
ATE432710T1 (de) Pharmazeutische zusammensetzungen, die diaminooxidase enthalten
WO2002053090A3 (fr) Association medicamenteuse d'une biguanine (metformine) et d'arginine
AR015362A1 (es) Uso de una composicion topicamente activa para la manufactura de un medicamento util para el tratamiento de acne vulgaris y/o para producir efectos anti-envejecimiento
CO4950526A1 (es) Composiciones retinoidestopicas y de serina proteasa utiles para el tratamiento de acne vulgaris y produccion de efectos anti-envejecimiento
UY23355A1 (es) Formulacion para verter destinada a la aplicacion de antihelminticos
AR011807A1 (es) Una composicion antitranspirante en aerosol sustancialmente anhidra para la aplicacion topica sobre la piel humana, y uso no terapeutico de dicha composicion.
UY26648A1 (es) Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada
ATE306248T1 (de) Artikel für die kosmetik oder die dermatologie, der eine gefriergetrocknete hydrokolloidzusammensetzung enthält
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.
CO5011042A1 (es) Uso de una oxazolidinona para la fabricacion de un medicamento para administracion topica
ES2152664T3 (es) Combinacion de cis-4-hidroxi-l-prolina y n-metil-cis-4-hidroxi-l-prolina para aplicacion como agente terapeutico, especialmente para el tratamiento contra el cancer.
GB2368523A (en) Solid wound healing formulations containing fibronectin

Legal Events

Date Code Title Description
FB Suspension of granting procedure